scholarly journals Tranexamic Acid Reduces Postoperative Blood Loss in Reverse Total Shoulder Arthroplasty

2021 ◽  
Vol 56 (5) ◽  
pp. 391
Author(s):  
Kee Young Park ◽  
In Bo Kim ◽  
Eun Yeol Kim ◽  
Kwang Suk Lee
Keyword(s):  
Blood Loss ◽  
Tranexamic Acid ◽  
Shoulder Arthroplasty ◽  
Total Shoulder Arthroplasty ◽  
Reverse Total Shoulder Arthroplasty ◽  
Postoperative Blood Loss ◽  
Reverse Total Shoulder

Impact of tranexamic acid on clinical and hematologic outcomes following total shoulder arthroplasty

2021 ◽  
pp. 175857322110230
Author(s):  
McKayla Kelly ◽  
Justin Turcotte ◽  
M Brook Fowler ◽  
Michaline West ◽  
Cyrus Lashgari ◽  
...  
Keyword(s):  
Length Of Stay ◽  
Tranexamic Acid ◽  
Shoulder Arthroplasty ◽  
Total Shoulder Arthroplasty ◽  
Univariate Analysis ◽  
Reverse Total Shoulder Arthroplasty ◽  
Complication Rates ◽  
Vein Thrombosis ◽  
Reverse Total Shoulder ◽  
The Impact

Background The purpose of this study is to evaluate the impact of intravenous tranexamic acid on clinical and hematologic outcomes after total shoulder arthroplasty. Methods Retrospective review was conducted for 282 consecutive patients undergoing either anatomic shoulder arthroplasty or reverse total shoulder arthroplasty. Univariate analysis and multivariate linear regression were used to compare outcomes for patients receiving intravenous tranexamic acid with those who did not. Results Of the 282 patients included in this study, 78 patients received intravenous tranexamic acid and 204 did not. Patients who received intravenous tranexamic acid had significantly lower pre- to postoperative change in hemoglobin and hematocrit, and decreased postoperative drain output. In addition, patients receiving intravenous tranexamic acid were significantly less likely to have a postoperative hematocrit <30. There were no significant differences in length of stay, rate of 30 day hematoma, surgical site infection, deep vein thrombosis, or readmission between groups. Conclusion Intravenous tranexamic acid is associated with a significant reduction in change in hematocrit and hemoglobin and postoperative drain output after both anatomic and reverse total shoulder arthroplasty. Despite improving hematologic outcomes for these patients, tranexamic acid appears to have little impact on clinical outcomes such as length of stay and 30-day complication rates.

Sign in / Sign up

Export Citation Format

Share Document